Thymic abnormalities in rare immunological diseases

Acronym

TARID

Description of the granted funding

Many rare diseases are caused by a malfunctioning immune system, which attacks the patient's own tissues in a process called autoimmunity. The treatment options are limited by the fact that the origin of such autoimmune attack is poorly understood. In the TARID project we study two rare diseases, Myasthenia gravis and APECED, which have as unifying features an inherited or acquired defect in Autoimmune Regulator (AIRE) -gene and the patients also share specific types of autoantibodies. AIRE normally works in the thymus, the organ responsible for generating T cells, key immune cells responsible for cellular immunity and immune regulation. Somehow the AIRE-deficiency also leads to production of high-affinity antibodies against self-antigens. The main aim of TARID consortium is to characterize how the loss of AIRE leads to autoantibody production. These results can elucidate also pathogenesis more common autoimmune diseases where autoantibodies are produced.
Show more

Starting year

2020

End year

2023

Granted funding


Eliisa Kekäläinen Orcid -palvelun logo
127 765 €

Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
University of Helsinki (334813)
127 759 €

Funder

Research Council of Finland

Funding instrument

Kansainvälinen yhteisrahoitteinen ohjelma

Other information

Funding decision number

334812

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

genes, genetics